Smruthi Organic

Why is Smruthi Organics Ltd falling/rising?

As of 10-Jun, Smruthi Organics Ltd's stock price is Rs 117.15, down 2.7%, and has underperformed the sector. The stock has shown a significant decline over the past year and five years, indicating bearish sentiment among investors.

As of 10-Jun, Smruthi Organics Ltd's stock price is falling, currently at Rs 117.15, which reflects a decrease of Rs 3.25 or 2.7%. The stock has underperformed compared to the sector by 2.24% today and has experienced a trend reversal, falling after three consecutive days of gains. The stock reached an intraday low of Rs 117, indicating a decline of 2.82% during the trading session.<BR><BR>Over the past week, the stock has decreased by 3.42%, while the benchmark Sensex has only fallen by 0.49%. In the last month, Smruthi Organics Ltd has seen a decline of 2.74%, which is a better performance compared to the Sensex's drop of 4.33%. However, on a year-to-date basis, the stock has only slightly increased by 0.21%, contrasting with the Sensex's significant decline of 13.19%. <BR><BR>The stock's performance over longer periods shows a more concerning trend, with a 10.26% decline over the past year and a substantial 62.99% drop over the last five years, while the Sensex has increased by 41.46% in the same timeframe. <BR><BR>Additionally, the moving averages indicate that the stock is currently lower than the 5-day, 20-day, and 200-day moving averages, which may suggest a bearish sentiment among investors. Despite a rise in delivery volume by 44.03% against the 5-day average, the overall liquidity remains adequate for trading, but the negative price movement indicates a lack of confidence in the stock's short-term prospects.

Which are the latest news on Smruthi Organic?

How big is Smruthi Organic?

As of 10th June, Smruthi Organics Ltd has a market capitalization of 138.00 Cr, with recent net sales of 101.97 Cr and a net profit of 3.43 Cr.

As of 10th June, Smruthi Organics Ltd has a market capitalization of 138.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Smruthi Organics reported Net Sales of 101.97 Cr and a Net Profit of 3.43 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 71.63 Cr and Total Assets valued at 111.74 Cr.

What does Smruthi Organic do?

Smruthi Organics Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, incorporated in 1989, with recent net sales of 29 Cr and net profit of 1 Cr as of March 2026. Key metrics include a P/E of 35.00, a dividend yield of 1.23%, and a market cap of INR 138 Cr.

Overview: <BR>Smruthi Organics Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History: <BR>Smruthi Organics Limited was incorporated in July 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February 1995. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 29 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 1 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 138 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 35.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 1.23% <BR>Debt Equity: 0.08 <BR>Return on Equity: 5.20% <BR>Price to Book: 1.90 <BR><BR>Contact Details: <BR>Address: 165-A Balaji Bhavan 1st Floor, Railway Lines Solapur Maharashtra : 413001 <BR>Tel: 91-217-2310267/2310268 <BR>Email: changale@smruthiorganics.com <BR>Website: http://www.smruthiorganics.com

Should I buy, sell or hold Smruthi Organics Ltd?

Are Smruthi Organics Ltd latest results good or bad?

Smruthi Organics Ltd's latest results are unfavorable, showing a 52.02% decline in net profit and a 23.63% drop in revenue year-on-year, despite a sequential revenue increase. Overall, the company's financial performance indicates operational challenges and underperformance compared to the pharmaceuticals sector.

Smruthi Organics Ltd's latest results indicate a challenging situation for the company. In the fourth quarter of FY26, the company reported a net profit of ₹1.07 crore, which is a significant decline of 52.02% year-on-year. Revenue also fell by 23.63% compared to the same quarter last year, totaling ₹29.09 crore. While there was a sequential improvement in revenue, with a 30.51% increase from the previous quarter, this does not offset the overall decline when viewed year-on-year.<BR><BR>The operating margin improved slightly to 13.03%, but the profit after tax (PAT) margin decreased to 3.68%, down from 5.85% in the same quarter last year. Additionally, the company's performance over the past year has been weak, with a return of only 1.41%, significantly underperforming the pharmaceuticals sector's average return of 10.24%.<BR><BR>Overall, the financial results reflect underlying operational challenges and a concerning trend of declining revenues and profits, which suggests that the latest results are not favorable for Smruthi Organics Ltd. Investors may need to be cautious given these indicators of financial health.

When is the next results date for Smruthi Organics Ltd?

The next results date for Smruthi Organics Ltd is 13 May 2026.

The next results date for Smruthi Organics Ltd is scheduled for 13 May 2026.

How has been the historical performance of Smruthi Organic?

Smruthi Organic's historical performance shows declining net sales and total operating income from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025, despite a decrease in raw material costs and an increase in operating profit. Overall, the company has faced mixed financial results with fluctuating profits and cash flow.

Answer:<BR>The historical performance of Smruthi Organic shows a fluctuating trend in key financial metrics over the past several years.<BR><BR>Breakdown:<BR>Smruthi Organic's net sales have seen a decline from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025, with a peak in March 2023. The total operating income followed a similar trend, dropping from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025. The raw material costs decreased significantly from INR 95.69 crore in March 2023 to INR 67.86 crore in March 2025, contributing to a reduction in total expenditure, which fell from INR 131.26 crore in March 2023 to INR 113.83 crore in March 2025. Operating profit (PBDIT) has also fluctuated, reaching INR 12.27 crore in March 2025, up from INR 9.89 crore in March 2023. However, profit before tax showed a slight increase from INR 4.49 crore in March 2023 to INR 4.90 crore in March 2025, while profit after tax decreased from INR 4.13 crore in March 2023 to INR 3.56 crore in March 2025. The company's total assets increased from INR 105.64 crore in March 2023 to INR 111.74 crore in March 2025, while total liabilities rose from INR 105.64 crore to INR 111.74 crore in the same period. Cash flow from operating activities improved to INR 9.00 crore in March 2025 from INR 12.00 crore in March 2023, indicating a mixed performance in cash generation. Overall, Smruthi Organic's financial performance reflects a challenging environment with varying trends in sales, profits, and expenses.

Who are the top shareholders of the Smruthi Organic?

The top shareholders of Smruthi Organic are mainly promoters, with Eaga Purushotham Malaiah holding 41.23%. The highest public shareholder is Smitha Gupta at 1.21%, while individual investors collectively own 28.81% of the shares.

The top shareholders of Smruthi Organic are primarily the promoters, with Eaga Purushotham Malaiah holding the largest stake at 41.23%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Smitha Gupta, who owns 1.21%. Additionally, individual investors collectively hold 28.81% of the shares.

Is Smruthi Organic overvalued or undervalued?

As of May 6, 2025, Smruthi Organic is considered undervalued with a PE ratio of 41.20 and an attractive valuation compared to peers, despite a recent 1-year return of -19.68%, while maintaining a strong long-term outlook with a 5-year return of 311.48%.

As of 6 May 2025, the valuation grade for Smruthi Organic has moved from expensive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued. Key ratios include a PE ratio of 41.20, an EV to EBITDA of 13.44, and a PEG ratio of 0.00, which suggests potential for growth relative to its price.<BR><BR>In comparison to its peers, Smruthi Organic's PE ratio is higher than Sun Pharma's 35.25 but lower than Divi's Lab's significantly high 79.33. Additionally, while Cipla has an attractive valuation with an EV to EBITDA of 15.93, Smruthi's lower EV to EBITDA indicates it may be undervalued relative to its earnings potential. Notably, despite recent underperformance with a 1-year return of -19.68% compared to the Sensex's 7.62%, the long-term outlook remains positive with a 5-year return of 311.48%.

What is the technical trend for Smruthi Organic?

As of May 12, 2025, Smruthi Organic's trend is mildly bearish, with conflicting signals from weekly indicators showing mild bullishness and monthly indicators remaining bearish.

As of 12 May 2025, the technical trend for Smruthi Organic has changed from bearish to mildly bearish. The weekly MACD and KST are both mildly bullish, indicating some positive momentum, while the monthly MACD and KST remain bearish. The Bollinger Bands also show a mildly bullish stance on the weekly timeframe but are bearish on the monthly. Daily moving averages indicate a mildly bearish trend. Overall, the current stance is mildly bearish, driven primarily by the conflicting signals between the weekly and monthly indicators.

Who are in the management team of Smruthi Organic?

As of March 2023, the management team of Smruthi Organic includes E Purushotham (Chairman & Managing Director), E Swapnil (Joint Managing Director & CFO), and several independent directors, along with a Company Secretary. They oversee the company's operations and strategic direction.

As of March 2023, the management team of Smruthi Organic includes:<BR><BR>1. E Purushotham - Chairman & Managing Director<BR>2. E Swapnil - Joint Managing Director & CFO<BR>3. J H Ranade - Independent Director<BR>4. K Ramaswamy - Independent Director<BR>5. Kashinath R Dhole - Independent Director<BR>6. Urvashi D Khanna - Company Secretary & Compliance Officer<BR>7. E. Smruthi - Non-Executive & Non-Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

What is the bonus history of the Smruthi Organic?

Smruthi Organic announced a 2:1 bonus issue on March 16, 2021, with a record date of March 17, 2021, allowing shareholders to receive two additional shares for every one share held.

Smruthi Organic has a bonus history that includes a 2:1 bonus issue announced on March 16, 2021. The record date for this bonus was March 17, 2021. This means that shareholders received two additional shares for every one share they held as of the record date. If you have any more questions about the company or its financial activities, feel free to ask!

Has Smruthi Organic declared dividend?

Yes, Smruthi Organics Ltd has declared a 15% dividend, amounting to ₹1.5 per share, with an ex-date of June 13, 2025. Despite recent volatility, the company has shown a strong recovery over the past five years, yielding a total return of 279.01%.

Smruthi Organics Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 15%<BR>- Amount per share: 1.5<BR>- Ex-date: 13 Jun 25<BR><BR>Dividend Yield: 1.16%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -1.08%, the dividend return was 1.17%, resulting in a total return of 0.09%.<BR><BR>Over the past year, the price return was -21.76%, with a dividend return of 1.75%, leading to a total return of -20.01%.<BR><BR>In the 2-year period, the price return was -12.23%, while the dividend return was 3.86%, resulting in a total return of -8.37%.<BR><BR>For the 3-year period, the price return was -27.96%, the dividend return was 5.03%, culminating in a total return of -22.93%.<BR><BR>In the last 4 years, the price return was -50.94%, with a dividend return of 3.54%, resulting in a total return of -47.4%.<BR><BR>Finally, over the 5-year period, the price return was 252.55%, the dividend return was 26.46%, leading to a total return of 279.01%.<BR><BR>Overall, while Smruthi Organics Ltd has declared a dividend, the total returns over various periods show significant volatility, with negative returns in most periods except for the 5-year period, which indicates a strong recovery in the long term.

Who are the peers of the Smruthi Organic?

Smruthi Organic's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, and others. In terms of performance, Smruthi Organic has a 1-year return of -22.54%, with growth and management risk rated below average compared to its peers.

Peers: The peers of Smruthi Organic are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Denis Chem Lab, BDH Industries, Tyche Industries, Quest, and Sotac Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, BDH Industries, Tyche Industries, and Quest, while Average management risk is found at Denis Chem Lab. Growth is excellent at Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while below average growth is noted for Divi's Lab., Torrent Pharma, Smruthi Organic, Denis Chem Lab, BDH Industries, and Tyche Industries. Excellent capital structure is seen in Sun Pharma.Inds., Cipla, Dr Reddy's Labs, Smruthi Organic, Denis Chem Lab, BDH Industries, Tyche Industries, and the rest.<BR><BR>Return Snapshot: Divi's Lab. has the highest 1-year return at 51.96%, while Denis Chem Lab has the lowest at -38.43%. Smruthi Organic's 1-year return is -22.54%, which is significantly lower than Divi's Lab. and higher than Denis Chem Lab. Additionally, BDH Industries, Tyche Industries, and Denis Chem Lab have negative six-month returns.